Clinical Trial Update: Fostamatinib for Treating Acute Respiratory Distress Syndrome (ARDS) in Hospitalized Adults [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial to evaluate fostamatinib for Acute Respiratory Distress Syndrome (ARDS) in hospitalized adults; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Distress Syndrome

Drugs mentioned

• Fostamatinib (fostamatinib)

Snippet

Sponsor: Inova Health Care Services | Conditions: Acute Respiratory Distress Syndrome, ARDS | Phase 2 | Status: NOT_YET_RECRUITING